• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 15-12G filed by Surgalign Holdings Inc.

    11/13/23 4:08:28 PM ET
    $SRGA
    Industrial Specialties
    Health Care
    Get the next $SRGA alert in real time by email
    15-12G 1 ea188077-1512g_surgalign.htm FORM 15-12G

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

     

    FORM 15

     

     

     

    Certification and Notice of Termination of Registration

    under Section 12(g) of the Securities Exchange Act of 1934

    or Suspension of Duty to File Reports Under Sections 13 and 15(d)

    of the Securities Exchange Act of 1934.

     

    Commission File Number: 001-38832

     

     

     

    SURGALIGN HOLDINGS, INC.

    (Exact name of registrant as specified in its charter)

     

     

     

    520 Lake Cook Road, Suite 315

    Deerfield, Illinois

    (877) 343-6832

    (Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)

     

    Common Stock, par value $0.001 per share

    (Title of each class of securities covered by this Form)

     

    None

    (Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)

     

     

     

    Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:

     

      Rule 12g-4(a)(1) ☒
      Rule 12g-4(a)(2) ☐
      Rule 12h-3(b)(1)(i) ☒
      Rule 12h-3(b)(1)(ii) ☐
      Rule 15d-6 ☐
      Rule 15d-22(b) ☐

     

    Approximate number of holders of record as of the certification or notice date:

     

    Common Stock, par value $0.01 per share: Zero

     

     

     

     

     

     

    EXPLANATORY NOTE

     

    On June 19, 2023, Surgalign Holdings, Inc. (the “Company”) and certain of its direct and indirect subsidiaries commenced voluntary proceedings under chapter 11 (the “Chapter 11 Cases”) of the United States Bankruptcy Code in the United States Bankruptcy Court for the Southern District of Texas. The Chapter 11 Cases are being jointly administered under the caption In re Surgalign Holdings, Inc., et al., Case Nos. 23-90730 through 23-90737.

     

    On October 2, 2023 (the “Effective Date”), the Company’s modified combined disclosure statement and joint chapter 11 plan of liquidation (the “Plan”) became effective. Pursuant to the Plan, all equity interests in the Company, including the common stock of the Company, were cancelled on the Effective Date and shall be of no further force and effect, whether surrendered for cancellation or otherwise. As a result, as of October 2, 2023, there are no holders of common stock of the Company.

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, Surgalign Holdings, Inc. has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.

     

    Date: November 13, 2023

     

      SURGALIGN HOLDINGS, INC.
           
      By: /s/ Steven Balasiano
        Name:  Steven Balasiano
        Title: Authorized Signatory

     

     

     

    Get the next $SRGA alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $SRGA

    DatePrice TargetRatingAnalyst
    9/28/2021$1.50Buy → Hold
    Craig Hallum
    More analyst ratings